At the AMCP Annual Meeting this week, experts from Prime Therapeutics said virtual navigation and clinical pathways are ...

In this interview, Luis Ortiz, M.D., explains the current and emerging therapies for narcolepsy type 1 treatment. Narcolepsy ...

Daily oral PrEP (generic Truvada; Descovy) is effective but adherence-sensitive, and seroconversions in trials correlate with ...

CVS Caremark’s preferred-formulary shift from tirzepatide to semaglutide produced a 17-fold jump in tirzepatide switching ...

Cancer therapeutics and orphan drugs are no longer niche areas. Specialty drugs are now a significant portion of the ...

The burden of living with narcolepsy is high, and it starts at a young age, according to Luis Ortiz, M.D., assistant ...

The Maximum Fair Price (MFP), established by the Inflation Reduction Act, allows CMS to negotiate prices for Medicare drugs.

Obesity therapeutics now represent ~$98B and 4.6% share, climbing to the fourth-largest category, with ~190 pipeline assets ...

Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains how managed care organizations can ...

In this first part of a video interview series, Abby Kim, Pharm.D., of Prime Therapeutics shows how advances such as ...

CAR-T cell therapy has spread into earlier lines of care over the last ten years, going beyond heavily pretreated populations ...

Pfizer and BioMarin have pulled their hemophilia gene therapies, citing low demand. To prepare for his presentation at the ...